bioRxivMicrobiologyPreprint
Molecular characterization of extended-spectrum beta-lactamase-producing extra-intestinal pathogenic Escherichia coli isolated in a university teaching hospital Dakar-Senegal
K. M. DOSSOUVI, B. Sambe Ba, G. Lo, A. Cisse, A. Ba-Diallo, I. Ndiaye, A. Dieng, S. M. L. Ndiaye, C. Fall, A. Tine, F. Karam, H. Diagne-Samb, S. Ngom-Cisse, H. Diop-Ndiaye, C. Toure-Kane, A. Gaye-Diallo, S. Mboup, C. S. B. Boye, Y. Dieye, A. Seck, M. Camara
Abstract
Extra-intestinal pathogenic Escherichia coli (ExPEC), a predominant Gram-negative bacterial pathogen, express a wide range of virulence factors and is responsible of several diseases including urinary tract infections (UTI), nosocomial pneumonia, bacteremia, and neonatal meningitis. ExPEC isolates are often multidrug resistant (MDR) and clones producing extended-spectrum beta-lactamases (ESBL) are increasingly reported all over the world. Seventy-eight clinical ExPEC strains were selected for this study. The majority was from UTIs (n=51), while the rest (n=27) was from pus, sputum, bronchial fluid and vaginal samples (non-uropathogenic ExPEC). Interestingly, 49 out of the 78 ExPEC isolates where considered as community-acquired (CA) and 29 hospital-acquired (HA) bacteria. Antibiotic susceptibility testing was performed using the Kirby-Bauer disc diffusion method. Standard polymerase chain reaction (PCR) was used to screen major ESBL genes (blaCTX-M, blaOXA-1, blaTEM, blaSHV) and blaCTX-M variants (blaCTX-M-1, blaCTX-M-9, blaCTX-M-15, blaCTX-M-25). All the ExPEC strains were resistant to ampicillin, ticarcillin, amoxicillin/clavulanic acid combination, cefalotin, cefotaxime, ceftazidime, cefepime and aztreonam, but showed a high susceptibity to fosfomycin (98.7%, n = 77), ertapenem (96.2%, n = 75), and imipenem (100%). Moreover, isolates harbored at least one ESBL gene, including blaCTX-M (98.7%), blaOXA-1 (78.2%), blaTEM (44.9%) and blaSHV (3.8%). The CTX-M variants were also found with the predominance of blaCTX-M-1 (90.9%) and blaCTX-M-15 (90.9%) followed by blaCTX-M-9 (11.7%), while blaCTX-M-25 was not detected. Despite the resistance to most of the tested antibiotics, ExPEC isolates showed fortunately a good susceptibility to fosfomycin and carbapenems. blaCTX-M (blaCTX-M1, blaCTX-M15) and blaOXA-1 seem to be E. coli major ESBL genes circulating in Senegal. No significant difference was noted when comparing prevalence of ESBL genes detected from CA and HA strains, and from UPEC and non-uropathogenic ExPEC. The high level of resistance to antimicrobials observed stresses the need of establishing an epidemiological surveillance of antimicrobial resistance in both community and hospital settings.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Preliminary Occurrence of Extended-Spectrum and AmpC Beta-Lactamases in Clinical Isolates of Enteropathogenic Escherichia coli in Najaf, Iraq
H. A. Alsherees, S. N. A. Ali·bioRxiv·Jan 7, 2019
- Phenotypic and molecular characterization of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates from various samples of animal origin from Assam, India
Leena Das, Probodh Borah, … Rupam Dutta·bioRxiv·May 28, 2020
- Extended-spectrum beta-lactamase genes traverse the Escherichia coli populations of ICU patients, staff and environment.
R. A. Moran, L. Baomo, … A. McNally·bioRxiv·Dec 8, 2022
- Multidrug resistant E. coli isolate along with ESBL production and Antimicrobial Susceptibility pattern from patients of Urinary Tract Infection from tertiary care hospital, Delhi
Thakur Datt, Shyama Datt, … NP Singh·bioRxiv·Sep 5, 2025
- Extraintestinal pathogenic Escherichia coli (ExPEC) are associated with prolonged carriage of extended-spectrum β-lactamase-producing E. coli acquired during travel
B. C. van der Putten, J. M. van Hattem, … C. Schultsz·bioRxiv·Sep 23, 2020
- Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 - 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content
D. van Hout, T. D. Verschuuren, … J. A. J. W. Kluytmans·bioRxiv·Oct 21, 2019